JAHA:美国心脏骤停成年患者体外膜肺氧合治疗结局

2021-10-11 MedSci原创 MedSci原创

人口统计学指标和治疗因素与接受ECMO的心脏骤停患者死亡率独立相关。确定哪些心脏骤停患者可以从ECMO中获得最大利益,可能有助于做出临床决策。

接受体外膜肺氧合(ECMO)的心脏骤停成人预后不良相关的因素仍未明确。

近日,血管疾病领域权威杂志JAHA上发表了一篇研究文章,研究人员旨在通过全国代表性样本确定接受ECMO的心脏骤停成人死亡率的预测因素。

研究人员通过美国医疗保健成本和利用项目的全国住院患者样本用于确定了782名在2006年至2014年期间接受ECMO治疗的住院心脏骤停成人。该研究的主要结局是全因住院死亡率。研究人员使用多变量Logistic回归分析与死亡率相关的因素。

总体住院死亡率为60.4%(n=472)。死亡患者年龄较大,通常为男性,非白种人,家庭收入低于幸存出院的患者。在风险调整分析中,死亡的独立预测因素包括年龄较大、男性、年收入较低、没有室性心律失常、没有经皮冠状动脉介入治疗以及治疗性低温。

由此可见,人口统计学指标和治疗因素与接受ECMO的心脏骤停患者死亡率独立相关。确定哪些心脏骤停患者可以从ECMO中获得最大利益,可能有助于做出临床决策。需要更大规模的研究来评估心脏骤停时采用ECMO治疗的合适候选者。

原始出处:

George Gill.et al.Outcomes of Venoarterial Extracorporeal Membrane Oxygenation for Cardiac Arrest in Adult Patients in the United States.JAHA.2021.https://www.ahajournals.org/doi/full/10.1161/JAHA.121.021406

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1694911, encodeId=bd57169491116, content=<a href='/topic/show?id=ce9b64692d2' target=_blank style='color:#2F92EE;'>#治疗结局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64692, encryptionId=ce9b64692d2, topicName=治疗结局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d1829785524, createdName=zhangjiqing, createdTime=Tue Oct 26 07:28:40 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268647, encodeId=7d9e126864eac, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Wed Oct 13 12:28:40 CST 2021, time=2021-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059668, encodeId=d4021059668fb, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210901/969603a2377544169c0528539edd5ab7/50bbe992202d43569f6cc40d89829e36.jpg, createdBy=b54c5537441, createdName=智慧药, createdTime=Tue Oct 12 09:14:12 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059657, encodeId=3f6e105965e23, content=医生技术越来越好, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210914/64ab02e7412e4bb9bd16761e5ec01d40/f4b009acb5ad48ebbc530cb9d15a3aaa.jpg, createdBy=a57f5584285, createdName=ms9000000575742753, createdTime=Tue Oct 12 08:04:34 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059647, encodeId=10b8105964e75, content=可否满意不要不要狙击手术气死了没, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Tue Oct 12 07:32:43 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059636, encodeId=a3da105963667, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/e9408422a23545ef9738dd674abfc4ff/c719925083844b82986bc39d43051172.jpg, createdBy=8eb14795142, createdName=与狼共舞, createdTime=Tue Oct 12 06:07:23 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059635, encodeId=21ae1059635ad, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7a31928393, createdName=学医无涯, createdTime=Tue Oct 12 06:05:36 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059620, encodeId=33541059620e0, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Oct 11 23:50:39 CST 2021, time=2021-10-11, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1694911, encodeId=bd57169491116, content=<a href='/topic/show?id=ce9b64692d2' target=_blank style='color:#2F92EE;'>#治疗结局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64692, encryptionId=ce9b64692d2, topicName=治疗结局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d1829785524, createdName=zhangjiqing, createdTime=Tue Oct 26 07:28:40 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268647, encodeId=7d9e126864eac, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Wed Oct 13 12:28:40 CST 2021, time=2021-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059668, encodeId=d4021059668fb, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210901/969603a2377544169c0528539edd5ab7/50bbe992202d43569f6cc40d89829e36.jpg, createdBy=b54c5537441, createdName=智慧药, createdTime=Tue Oct 12 09:14:12 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059657, encodeId=3f6e105965e23, content=医生技术越来越好, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210914/64ab02e7412e4bb9bd16761e5ec01d40/f4b009acb5ad48ebbc530cb9d15a3aaa.jpg, createdBy=a57f5584285, createdName=ms9000000575742753, createdTime=Tue Oct 12 08:04:34 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059647, encodeId=10b8105964e75, content=可否满意不要不要狙击手术气死了没, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Tue Oct 12 07:32:43 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059636, encodeId=a3da105963667, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/e9408422a23545ef9738dd674abfc4ff/c719925083844b82986bc39d43051172.jpg, createdBy=8eb14795142, createdName=与狼共舞, createdTime=Tue Oct 12 06:07:23 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059635, encodeId=21ae1059635ad, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7a31928393, createdName=学医无涯, createdTime=Tue Oct 12 06:05:36 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059620, encodeId=33541059620e0, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Oct 11 23:50:39 CST 2021, time=2021-10-11, status=1, ipAttribution=)]
    2021-10-13 zhaohui6731
  3. [GetPortalCommentsPageByObjectIdResponse(id=1694911, encodeId=bd57169491116, content=<a href='/topic/show?id=ce9b64692d2' target=_blank style='color:#2F92EE;'>#治疗结局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64692, encryptionId=ce9b64692d2, topicName=治疗结局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d1829785524, createdName=zhangjiqing, createdTime=Tue Oct 26 07:28:40 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268647, encodeId=7d9e126864eac, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Wed Oct 13 12:28:40 CST 2021, time=2021-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059668, encodeId=d4021059668fb, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210901/969603a2377544169c0528539edd5ab7/50bbe992202d43569f6cc40d89829e36.jpg, createdBy=b54c5537441, createdName=智慧药, createdTime=Tue Oct 12 09:14:12 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059657, encodeId=3f6e105965e23, content=医生技术越来越好, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210914/64ab02e7412e4bb9bd16761e5ec01d40/f4b009acb5ad48ebbc530cb9d15a3aaa.jpg, createdBy=a57f5584285, createdName=ms9000000575742753, createdTime=Tue Oct 12 08:04:34 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059647, encodeId=10b8105964e75, content=可否满意不要不要狙击手术气死了没, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Tue Oct 12 07:32:43 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059636, encodeId=a3da105963667, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/e9408422a23545ef9738dd674abfc4ff/c719925083844b82986bc39d43051172.jpg, createdBy=8eb14795142, createdName=与狼共舞, createdTime=Tue Oct 12 06:07:23 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059635, encodeId=21ae1059635ad, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7a31928393, createdName=学医无涯, createdTime=Tue Oct 12 06:05:36 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059620, encodeId=33541059620e0, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Oct 11 23:50:39 CST 2021, time=2021-10-11, status=1, ipAttribution=)]
    2021-10-12 智慧药

    学习学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1694911, encodeId=bd57169491116, content=<a href='/topic/show?id=ce9b64692d2' target=_blank style='color:#2F92EE;'>#治疗结局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64692, encryptionId=ce9b64692d2, topicName=治疗结局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d1829785524, createdName=zhangjiqing, createdTime=Tue Oct 26 07:28:40 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268647, encodeId=7d9e126864eac, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Wed Oct 13 12:28:40 CST 2021, time=2021-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059668, encodeId=d4021059668fb, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210901/969603a2377544169c0528539edd5ab7/50bbe992202d43569f6cc40d89829e36.jpg, createdBy=b54c5537441, createdName=智慧药, createdTime=Tue Oct 12 09:14:12 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059657, encodeId=3f6e105965e23, content=医生技术越来越好, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210914/64ab02e7412e4bb9bd16761e5ec01d40/f4b009acb5ad48ebbc530cb9d15a3aaa.jpg, createdBy=a57f5584285, createdName=ms9000000575742753, createdTime=Tue Oct 12 08:04:34 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059647, encodeId=10b8105964e75, content=可否满意不要不要狙击手术气死了没, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Tue Oct 12 07:32:43 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059636, encodeId=a3da105963667, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/e9408422a23545ef9738dd674abfc4ff/c719925083844b82986bc39d43051172.jpg, createdBy=8eb14795142, createdName=与狼共舞, createdTime=Tue Oct 12 06:07:23 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059635, encodeId=21ae1059635ad, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7a31928393, createdName=学医无涯, createdTime=Tue Oct 12 06:05:36 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059620, encodeId=33541059620e0, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Oct 11 23:50:39 CST 2021, time=2021-10-11, status=1, ipAttribution=)]
    2021-10-12 ms9000000575742753

    医生技术越来越好

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1694911, encodeId=bd57169491116, content=<a href='/topic/show?id=ce9b64692d2' target=_blank style='color:#2F92EE;'>#治疗结局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64692, encryptionId=ce9b64692d2, topicName=治疗结局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d1829785524, createdName=zhangjiqing, createdTime=Tue Oct 26 07:28:40 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268647, encodeId=7d9e126864eac, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Wed Oct 13 12:28:40 CST 2021, time=2021-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059668, encodeId=d4021059668fb, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210901/969603a2377544169c0528539edd5ab7/50bbe992202d43569f6cc40d89829e36.jpg, createdBy=b54c5537441, createdName=智慧药, createdTime=Tue Oct 12 09:14:12 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059657, encodeId=3f6e105965e23, content=医生技术越来越好, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210914/64ab02e7412e4bb9bd16761e5ec01d40/f4b009acb5ad48ebbc530cb9d15a3aaa.jpg, createdBy=a57f5584285, createdName=ms9000000575742753, createdTime=Tue Oct 12 08:04:34 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059647, encodeId=10b8105964e75, content=可否满意不要不要狙击手术气死了没, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Tue Oct 12 07:32:43 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059636, encodeId=a3da105963667, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/e9408422a23545ef9738dd674abfc4ff/c719925083844b82986bc39d43051172.jpg, createdBy=8eb14795142, createdName=与狼共舞, createdTime=Tue Oct 12 06:07:23 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059635, encodeId=21ae1059635ad, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7a31928393, createdName=学医无涯, createdTime=Tue Oct 12 06:05:36 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059620, encodeId=33541059620e0, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Oct 11 23:50:39 CST 2021, time=2021-10-11, status=1, ipAttribution=)]
    2021-10-12 查查佳佳

    可否满意不要不要狙击手术气死了没

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1694911, encodeId=bd57169491116, content=<a href='/topic/show?id=ce9b64692d2' target=_blank style='color:#2F92EE;'>#治疗结局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64692, encryptionId=ce9b64692d2, topicName=治疗结局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d1829785524, createdName=zhangjiqing, createdTime=Tue Oct 26 07:28:40 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268647, encodeId=7d9e126864eac, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Wed Oct 13 12:28:40 CST 2021, time=2021-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059668, encodeId=d4021059668fb, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210901/969603a2377544169c0528539edd5ab7/50bbe992202d43569f6cc40d89829e36.jpg, createdBy=b54c5537441, createdName=智慧药, createdTime=Tue Oct 12 09:14:12 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059657, encodeId=3f6e105965e23, content=医生技术越来越好, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210914/64ab02e7412e4bb9bd16761e5ec01d40/f4b009acb5ad48ebbc530cb9d15a3aaa.jpg, createdBy=a57f5584285, createdName=ms9000000575742753, createdTime=Tue Oct 12 08:04:34 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059647, encodeId=10b8105964e75, content=可否满意不要不要狙击手术气死了没, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Tue Oct 12 07:32:43 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059636, encodeId=a3da105963667, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/e9408422a23545ef9738dd674abfc4ff/c719925083844b82986bc39d43051172.jpg, createdBy=8eb14795142, createdName=与狼共舞, createdTime=Tue Oct 12 06:07:23 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059635, encodeId=21ae1059635ad, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7a31928393, createdName=学医无涯, createdTime=Tue Oct 12 06:05:36 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059620, encodeId=33541059620e0, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Oct 11 23:50:39 CST 2021, time=2021-10-11, status=1, ipAttribution=)]
    2021-10-12 与狼共舞

    学习学习

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1694911, encodeId=bd57169491116, content=<a href='/topic/show?id=ce9b64692d2' target=_blank style='color:#2F92EE;'>#治疗结局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64692, encryptionId=ce9b64692d2, topicName=治疗结局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d1829785524, createdName=zhangjiqing, createdTime=Tue Oct 26 07:28:40 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268647, encodeId=7d9e126864eac, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Wed Oct 13 12:28:40 CST 2021, time=2021-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059668, encodeId=d4021059668fb, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210901/969603a2377544169c0528539edd5ab7/50bbe992202d43569f6cc40d89829e36.jpg, createdBy=b54c5537441, createdName=智慧药, createdTime=Tue Oct 12 09:14:12 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059657, encodeId=3f6e105965e23, content=医生技术越来越好, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210914/64ab02e7412e4bb9bd16761e5ec01d40/f4b009acb5ad48ebbc530cb9d15a3aaa.jpg, createdBy=a57f5584285, createdName=ms9000000575742753, createdTime=Tue Oct 12 08:04:34 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059647, encodeId=10b8105964e75, content=可否满意不要不要狙击手术气死了没, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Tue Oct 12 07:32:43 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059636, encodeId=a3da105963667, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/e9408422a23545ef9738dd674abfc4ff/c719925083844b82986bc39d43051172.jpg, createdBy=8eb14795142, createdName=与狼共舞, createdTime=Tue Oct 12 06:07:23 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059635, encodeId=21ae1059635ad, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7a31928393, createdName=学医无涯, createdTime=Tue Oct 12 06:05:36 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059620, encodeId=33541059620e0, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Oct 11 23:50:39 CST 2021, time=2021-10-11, status=1, ipAttribution=)]
    2021-10-12 学医无涯

    学习一下

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1694911, encodeId=bd57169491116, content=<a href='/topic/show?id=ce9b64692d2' target=_blank style='color:#2F92EE;'>#治疗结局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64692, encryptionId=ce9b64692d2, topicName=治疗结局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d1829785524, createdName=zhangjiqing, createdTime=Tue Oct 26 07:28:40 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268647, encodeId=7d9e126864eac, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Wed Oct 13 12:28:40 CST 2021, time=2021-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059668, encodeId=d4021059668fb, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210901/969603a2377544169c0528539edd5ab7/50bbe992202d43569f6cc40d89829e36.jpg, createdBy=b54c5537441, createdName=智慧药, createdTime=Tue Oct 12 09:14:12 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059657, encodeId=3f6e105965e23, content=医生技术越来越好, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210914/64ab02e7412e4bb9bd16761e5ec01d40/f4b009acb5ad48ebbc530cb9d15a3aaa.jpg, createdBy=a57f5584285, createdName=ms9000000575742753, createdTime=Tue Oct 12 08:04:34 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059647, encodeId=10b8105964e75, content=可否满意不要不要狙击手术气死了没, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Tue Oct 12 07:32:43 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059636, encodeId=a3da105963667, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/e9408422a23545ef9738dd674abfc4ff/c719925083844b82986bc39d43051172.jpg, createdBy=8eb14795142, createdName=与狼共舞, createdTime=Tue Oct 12 06:07:23 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059635, encodeId=21ae1059635ad, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7a31928393, createdName=学医无涯, createdTime=Tue Oct 12 06:05:36 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059620, encodeId=33541059620e0, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Oct 11 23:50:39 CST 2021, time=2021-10-11, status=1, ipAttribution=)]
    2021-10-11 1209e435m98(暂无昵称)

    学习了,谢谢分享

    0

相关资讯

J Am Coll Cardiol:急性心肌梗塞和心脏骤停后休克患者的更佳血压值是多少?

对于急性心肌梗塞(AMI)后的休克患者,药物支持的最佳水平尚不清楚。高剂量的药物可能会增加心肌耗氧量并诱发心律失常,而舒张期低血压可能会减少冠状动脉灌注并增加梗塞面积。近日,研究人员探究了AMI和心脏

JAMA Netw Open:不同种族/民族心脏骤停发生率不同

心脏骤停 (SCA) 是一种极为严重的危及生命健康的因心脏的电活动异常,导致有效脉搏和血压丧失的急症,表现为发病突然,病情紧急,进展极快,是医院外各种环境、家庭和医院内最需争分夺秒抢救的疾病。

JACC:影响复苏抢救过的心脏骤停患者生存率的因素

心律失常原因、室性心动过速/纤颤初始节律和白种人都是复苏性心脏骤停患者存活的独立预测因素

Eur Heart J:达格列净对室性心律失常、心脏骤停或猝死的影响

在HFrEF患者的常规治疗中加入达格列净可降低任何严重室性心律失常、心脏骤停或猝死的风险。

JAHA:心肌梗塞后射血分数大于35%的患者心脏骤停的预测因素

射血分数(EF)降低的患者心肌梗塞(MI)后心脏骤停(SCA)风险增加。MI后EF>35%的患者年度SCA风险较大。